Survival Benefit for Patients With Metastatic Urothelial Carcinoma Receiving Continuous Maintenance Chemotherapy.
Chuang-Chi LiawTzu-Yao LiaoKe-Hung TsuiYu-Hsiang JuanPublished in: In vivo (Athens, Greece) (2019)
Continuous maintenance chemotherapy targeting chemo-sensitive tumors, administered at metronomic intervals and focus on tumor microenvironment, can increase MUC survival benefits.